Episode 3

Reagan Jarvis, Anocca

Published on: 7th May, 2026

What does it take to follow the science halfway round the world?

How do you persuade a team of brilliant scientists to go from asking questions to building solutions?

And why is “If you’re explaining, you’re losing” some of the worst advice in biotech?

Today I’m joined by Reagan Jarvis, CEO of Anocca. Anocca is a T-Cell biology biotech based near Stockholm, Sweden, and they’re building a platform to decipher T-cell targets and targeting constructs to develop personalised and precise T-cell therapies.

About LifeScience ORG

It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.

The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.

Chapters

01:35 — Following the Science Across the World

03:04 — From Postdoc Frustration to Founding a Company

04:37 — Taking the CEO Role

06:02 — Redirecting Scientists Toward Execution

10:59 — Communicating Differentiation in a Complex Field

13:53 — Lessons in Tone and Positioning

18:31 — Building Biotech in Europe

22:29 — Decoding T-Cell Biology and the Path to Personalised Therapies

32:39 — Leadership vs. Management

Next Episode All Episodes Previous Episode
Show artwork for A Call to Lead @LifeScience ORG

About the Podcast

A Call to Lead @LifeScience ORG
Sharing the leadership journeys of life science entrepreneurs shaping the future of healthcare.
A Call To Lead is a series shining a light on the leadership, vision, and impact of European life science CEOs who are proving that world-class ventures don’t need to be built in Boston to shape the future of healthcare.

Each episode features a one-on-one conversation with a European life science CEO and member of the LifeScience ORG community. Our conversations are not about companies or pipelines; instead, guests reflect on their personal journeys, the pivotal choices that shaped their careers, and the future they are helping to build. These kinds of insights are rarely shared publicly.

New episodes are released every Thursday.